Treatment of Pneumocystis in COPD (the TOPIC Study)

NCT05418777 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped lack of enrollment

Conditions

COPD Exacerbation Acute

Interventions

DRUG: Trimethoprim Sulfamethoxazole
DRUG: Placebo

Sponsor

Corewell Health East